Underwriters exercise overallotment option to purchase additional 480,000 shares in Pharmasset offering

Pharmasset, Inc. (Nasdaq: VRUS) announced today the underwriters of its recent stock offering have exercised their option to purchase an additional 480,000 shares of common stock. The net proceeds to Pharmasset, Inc., after deducting the underwriting discount, from the sale of these additional shares are expected to be approximately $13.2 million. This brings the total expected proceeds of the offering, after deducting the underwriting discount and estimated offering expenses, to $101.1 million. Citi is serving as sole book-running manager for the offering. J.P. Morgan, Baird and Canaccord Genuity are serving as co-managers.

Pharmasset granted the option in connection with its previously announced offering of 3,200,000 shares of common stock at an offering price of $29.00 per share, which is expected to close on May 19, 2010, subject to customary closing conditions.

Source:

 Pharmasset

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exercise temporarily improves muscle insulin resistance linked to genetic risk for type 2 diabetes